EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Functional Polymer‐Engineered Magnetic Nanoparticles as Dual‐Modal Theragnostic Probes for Early Alzheimer's Disease Detection and Therapy

Ao Shen, Liwen Zhang, Helen Forgham, Jiayuan Zhu, Xumin Huang, Changkui Fu, Ibrahim Javed, Thomas P. Davis, Ruirui Qiao

Advanced NanoBiomed Research · 2026-11 · 6 (11)

DOI: 10.1002/anbr.202600003 ↗
AbstractBibliografische Angaben

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by the deposition of amyloid‐beta (Aβ) plaques in the brain. Early diagnosis and effective targeted therapies remain critical challenges in managing AD. Herein, we present the design and development of novel functional polymer‐engineered magnetic nanoparticles for Aβ‐targeted diagnosis and therapeutic intervention. These nanoparticles feature a 3 nm iron oxide nanoparticle core for magnetic resonance imaging enhancement, as well as a functional polymer specifically engineered to target Aβ, exhibiting a fluorescence turn‐on response, colocalization and effective inhibition of Aβ fibrillation in vitro, highlighting their potential as a therapeutic agent for AD treatment. Our results suggest that polymer engineered magnetic nanoparticles hold promise as a versatile platform for AD diagnosis and targeted therapy, offering a potential solution for advancing AD management in clinics.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →